Location:
Sydney,
New South Wales
AUSTRALIA
•
Posted:
10 June 2010
•
Full details
Our Client is an unlisted public company formed in 2000 to acquire and develop a novel cancer biomarker and associated antibodies with a broad range of applications in cancer detection and treatment. Based in Sydney, the company is poised for expansion as it advances its patented antibodies into preclinical and ...